NCT05239338 Preserving Fertility After Colorectal Cancer Study
| NCT ID | NCT05239338 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Andreana Holowatyj, PhD, MSCI |
| Condition | Colorectal Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2021-12-06 |
| Primary Completion | 2036-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2021-12-06 with a primary completion date of 2036-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The PREFACE Study is a prospective, longitudinal cohort study of reproductive health and clinical outcomes among individuals diagnosed with colorectal cancer between age 18 to 49 years.
Eligibility Criteria
Inclusion Criteria: * Known diagnosis of colorectal cancer * Age 18 to 49 years at colorectal cancer diagnosis * Diagnosed by and/or consulting with a physician participating in the PREFACE Study * No prior history of colorectal cancer and/or colorectal cancer treatment * Mentally and physically able to consent and participate in the study Exclusion Criteria: * Women who are pregnant at the time of colorectal cancer diagnosis * Prisoners * Unable to provide informed consent * Unable to read, write, or complete questionnaires in English
Contact & Investigator
Andreana N Holowatyj, PhD, MSCI
PRINCIPAL INVESTIGATOR
Vanderbilt-Ingram Cancer Center
Frequently Asked Questions
Who can join the NCT05239338 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 49 Years, studying Colorectal Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05239338 currently recruiting?
Yes, NCT05239338 is actively recruiting participants. Contact the research team at prefacestudy@vumc.org for enrollment information.
Where is the NCT05239338 trial being conducted?
This trial is being conducted at Nashville, United States.
Who is sponsoring the NCT05239338 clinical trial?
NCT05239338 is sponsored by Andreana Holowatyj, PhD, MSCI. The principal investigator is Andreana N Holowatyj, PhD, MSCI at Vanderbilt-Ingram Cancer Center. The trial plans to enroll 1,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.